The interval between the first onset of CD symptoms and the first dose of anti-TNF therapy was negatively correlated with BMC, intracellular water, extracellular water, protein and BMR, suggesting that earlier anti-TNF therapy may improve these parameters in CD patients. The gene discussed is TNF; the disease is Cowden disease.